• Nota de aplicación

Oasis 2x4 Method: Proof of Concept

Oasis 2x4 Method: Proof of Concept

  • Waters Corporation
Blood plasma in gloved hands for PRP therapy

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief highlights Oasis 2x4 Method which is a viable approach to SPE sorbent and protocol selection.

Introduction

In order to prove that the Oasis 2x4 Method is a viable approach to SPE sorbent and protocol selection, a group of representative small molecules was spiked into rat plasma. The molecules include a base, a quaternary ammonium salt, a neutral, an acid and a strong acid. The spiked plasma samples were then extracted following the Oasis 2x4 Method. All molecules elute in the correct Elute 1 or Elute 2 fractions according to what theory predicted, proving that the method is viable.

Follow the simple steps outlined in this flow chart to achieve high recoveries and the cleanest extracts:

  • Characterize your analyte [Neutral, Acid or Base, pKa].
  • Select one of the four Oasis sorbents.
  • Apply the indicated Protocol [1 or 2].
  • Determine SPE recoveries by LC analysis.

Experimental

10 mg Oasis 96-well Plates

Protocol 1

Condition:

500 μL MeOH

Equilibrate:

500 μL H2O

Load:

500 μL sample (250 μL plasma diluted 1:1 with 4% H3PO4 in H2O)

Wash 1:

500 μL 2% HCOOH in H2O

Elution 1:

2 x 125 μL MeOH

Elution 2:

2 x 125 μL 5% NH4OH in MeOH

Dilution:

250 μL water

Protocol 2

Condition:

500 μL MeOH

Equilibrate:

500 μL H2O

Load:

500 μL sample (250 μL plasma diluted 1:1 with 4% H3PO4 in H2O)

Wash 1:

5% NH4OH in H2O

Elution 1:

2 x 125 μL MeOH

Elution 2:

2 x 125 μL 2% HCOOH in MeOH

Dilution:

5% NH4OH in H2O (To neutralize acid for high pH LC)

Column:

XBridge C18 2.1 x 20 mm IS, 3.5 μm

Mobile Phase A:

10 mM NH4HCO3, pH 10

Mobile Phase B:

10 mM NH4H

Injection Volume:

10.0 μ L

Column Temperature:

Ambient

Detection:

UV @ 254 nm (Prednisone)

Instrumentation:

2777 Sample Manager, 1525μ Binary HPLC Pump, Quattro Premier and 2996 PDA

Gradient

Time (min)

Profile

%A

%B

0

95

5

3.0

5

95

4.8

5

95

5.0

95

5

7.0

95

5

Quattro Premier

Capillary:

3.4 kV

Source Temp.:

120 °C

Desolvation Temp.:

350 °C

Cone Gas Flow:

50 L /Hr

Desolvation Gas Flow:

700 L /Hr

Collision Cell Pressure:

2.59e-3 mbar

MRM Transitions:

Imipramine 281.2 > 85.95 ESI+

Decanesulfonic Acid 220.9 > 79.7 ESI -

Ibuprofen 205.2 > 161 ESI -

Valethamate 306.3 > 162.8 ESI+

Results and Discussion

Elute 2, Primary Analyte Data

Primary Analyte Data

Prednisone SPE Recovery Data

Prednisone SPE Recovery Data

Elute 1, Counter Analyte Data

Elute 1, Counter Analyte Data

WA60090, June 2007

Volver arriba Volver arriba